ConductScience.org, home

Paper28486997

The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis.

Alqaisi AQI and 4 others. Parasitology, 2018. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis. Papers, record 28486997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28486997

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis.
PubMed
Journal
Parasitology
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2019-01-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alqaisi AQIA Q I
2Mbekeani AJA J
3Llorens MBM Bassas
4Elhammer APA P
5Denny PWP W

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
DepsipeptidesMajor topic
SphingolipidsMajor topic
ToxoplasmaMajor topic
Animals
Fibroblasts
Foreskin
Hexosyltransferases
Humans
Life Cycle Stages
Male
Toxoplasmosis
Toxoplasmosis, Animal

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in28595661The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis - Corrigendum.https://conductscience.org/library/papers/28595661

Source PubMed

Download CSV of comments and corrections

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123449981Ceramide phosphoethanolamine biosynthesis in Drosophila is mediated by a unique ethanolamine phosphotransferase in the Golgi lumen.J Biol Chem2013https://conductscience.org/library/papers/23449981PubMed
215973004Sphingolipids in infectious diseases.Jpn J Infect Dis2005https://conductscience.org/library/papers/15973004PubMed
319047657Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19047657PubMed
48593016The AUR1 gene in Saccharomyces cerevisiae encodes dominant resistance to the antifungal agent aureobasidin A (LY295337).Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8593016PubMed
516861742The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase.J Biol Chem2006https://conductscience.org/library/papers/16861742PubMed
612912895Formation and remodeling of inositolphosphoceramide during differentiation of Trypanosoma cruzi from trypomastigote to amastigote.Eukaryot Cell2003https://conductscience.org/library/papers/12912895PubMed
714685263Identification of a family of animal sphingomyelin synthases.EMBO J2004https://conductscience.org/library/papers/14685263PubMed
815569002Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.Biochem J2005https://conductscience.org/library/papers/15569002PubMed
923246819Sphingolipid synthesis and scavenging in the intracellular apicomplexan parasite, Toxoplasma gondii.Mol Biochem Parasitol2013https://conductscience.org/library/papers/23246819PubMed
1017404298Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling.J Immunol2007https://conductscience.org/library/papers/17404298PubMed
1124162026Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.Nat Rev Microbiol2013https://conductscience.org/library/papers/24162026PubMed
129092515Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene.J Biol Chem1997https://conductscience.org/library/papers/9092515PubMed
1311166384Biosynthesis of glycosphingolipids de-novo by the human malaria parasite Plasmodium falciparum.Mol Biochem Parasitol2001https://conductscience.org/library/papers/11166384PubMed
1423615442Toxoplasma gondii salvages sphingolipids from the host Golgi through the rerouting of selected Rab vesicles to the parasitophorous vacuole.Mol Biol Cell2013https://conductscience.org/library/papers/23615442PubMed
1526101567Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A.ACS Med Chem Lett2015https://conductscience.org/library/papers/26101567PubMed
168206135Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro.Exp Parasitol1994https://conductscience.org/library/papers/8206135PubMed
1712062486Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii.Int J Parasitol2002https://conductscience.org/library/papers/12062486PubMed
181429697Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids.J Biol Chem1992https://conductscience.org/library/papers/1429697PubMed
1927470411Human toxoplasmosis-Searching for novel chemotherapeutics.Biomed Pharmacother2016https://conductscience.org/library/papers/27470411PubMed
209177342Functional rafts in cell membranes.Nature1997https://conductscience.org/library/papers/9177342PubMed

See all 35 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
41708645Molecular insights into fungal inositol phosphorylceramide synthesis and its inhibition by antifungal aureobasidin A.Nat Commun2026https://conductscience.org/library/papers/41708645PubMed
37795915Toxoplasma ceramide synthases: Gene duplication, functional divergence, and roles in parasite fitness.FASEB J2023https://conductscience.org/library/papers/37795915PubMed
37729272Disruption of the inositol phosphorylceramide synthase gene affects Trypanosoma cruzi differentiation and infection capacity.PLoS Negl Trop Dis2023https://conductscience.org/library/papers/37729272PubMed
35977499Ceramide biosynthesis is critical for establishment of the intracellular niche of Toxoplasma gondii.Cell Rep2022https://conductscience.org/library/papers/35977499PubMed
32825250Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway.J Fungi (Basel)2020https://conductscience.org/library/papers/32825250PubMed
31120963Expression levels of inositol phosphorylceramide synthase modulate plant responses to biotic and abiotic stress in Arabidopsis thaliana.PLoS One2019https://conductscience.org/library/papers/31120963PubMed
30158461Functional Analyses of a Putative, Membrane-Bound, Peroxisomal Protein Import Mechanism from the Apicomplexan Protozoan Toxoplasma gondii.Genes (Basel)2018https://conductscience.org/library/papers/30158461PubMed
30088074Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.Parasitol Res2018https://conductscience.org/library/papers/30088074PubMed
29143719Microbial protein targets: towards understanding and intervention.Parasitology2018https://conductscience.org/library/papers/29143719PubMed
28637533Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis.Parasitology2018https://conductscience.org/library/papers/28637533PubMed
28595661The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis - Corrigendum.Parasitology2018https://conductscience.org/library/papers/28595661PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SGMS2166929PubTator's text mininghttps://conductscience.org/library/genes/166929

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28486997

GET https://conductscience.org/api/papers/v1/28486997/references?page=2